Showing 34,879 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Hepatitis B

Ongoing hepatitis B virus replication associated with higher mortality for people with HIV

News
16 August 2016
Activism & civil society

Are we losing our passion as AIDS activists?

Editor's pick
BETA blog
16 August 2016
Hepatitis C treatment

New research supports the removal of drug use as a restriction to hepatitis C treatment

Editor's pick
EurekAlert
15 August 2016
Epidemiology & behaviour

Are we 'Generation Bareback'?

Editor's pick
FS
15 August 2016
Employment

What It's Like to Tell Your Boss That You're HIV Positive

Editor's pick
Vice
15 August 2016
TB treatment

Patients with TB and HIV should receive prompt coordinated treatment for both conditions

Editor's pick
Eurekalert Inf Dis
15 August 2016
Harm reduction

Time for Safer Spaces

Editor's pick
Injecting Advice
15 August 2016
Government, leadership & policy

As Trump Vice President, Mike Pence Would Be a Nightmare for People With HIV

Editor's pick
The Body
15 August 2016
Contraception

Hormonal contraception and the risk of HIV acquisition in women

Editor's pick
World Health Organization
15 August 2016
PrEP

Mike Freer: Evaluating this anti-HIV drug should be based on clinical effectiveness – not prejudice over life choices

Editor's pick
Conservative Home
15 August 2016
Vaginal rings & topical PrEP

Vaginal bacteria increase HIV susceptibility and may reduce PrEP effectiveness

News
15 August 2016
Pharmaceutical industry

Gilead bags Genmab tech to develop bispecific antibody against HIV

Editor's pick
FierceBiotech
12 August 2016
Changing treatment

Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options

News
12 August 2016
PrEP

Why Doesn’t NHS England Want to Be Responsible for Preventing HIV?

Editor's pick
National AIDS Trust
11 August 2016
PrEP

How the HIV-prevention drug could break the NHS

Editor's pick
The Spectator
11 August 2016
PrEP programmes & uptake

No new HIV infections seen in San Francisco's Strut PrEP programme

News
11 August 2016
The search for a cure

Can immunotherapy cure HIV?

Editor's pick
Fred Hutch News Service
10 August 2016
Mental & emotional health problems

Efavirenz appears to be associated with elevated suicide risk in START trial

News
10 August 2016
PrEP

NHS Responds To Accusations Of Homophobia Over HIV Prevention Drug Statement

Editor's pick
BuzzFeed News
9 August 2016
Drug-resistant TB

HIV is not a super-spreader of drug-resistant tuberculosis

Editor's pick
EurekAlert (press release)
9 August 2016
Access to healthcare

Do trade deals threaten India as low-cost HIV drug maker?

Editor's pick
Politifact
9 August 2016
Global health targets

Rhetoric meets reality: ending HIV and AIDS

Editor's pick
Open Democracy
9 August 2016
Condoms & lubricant

Is Zimbabwe’s condom use per person the highest in the world?

Editor's pick
Africa Check
9 August 2016
Opportunistic infections

A detectable CMV viral load could signal a high risk of mortality in older individuals hospitalised with HIV-associated TB

News
9 August 2016